Business

GSK has announced strong quarterly results, reporting sales of £7.8 billion and growth in various sectors of the business.   Overall, the company’s adjusted operating profit for the third quarter came in at £2.6 billion, a 17% increase compared to the same period last year and reflecting a 4% year-on-growth at CER.   The quarterly results are […]

Clinical-stage company Respira Technologies has appointed a new Chief Executive Officer (CEO) to the company.  Brian Quigley will take over as CEO after working as Respira’s Chief Operating Officer (COO) for the past two years.   Quigley previously worked at Altria Group for 16 years where he spent seven years as President & CEO at Altria’s […]

Artificial intelligence (AI) company Atomwise has signed an exclusive research collaboration with Sanofi to use its AtomNet platform for computational discovery and research of up to five drug targets.  The agreement will see Atomwise receive $20 million from Sanofi to identify, synthesise, and advance lead compounds for up to five targets, which will be exclusive to […]

Clinical-stage drug discovery company Ryvu Therapeutics has received €22 million from the European Investment Bank (EIB) to help it advance its portfolio of cancer treatments.   The funding, which is being provided under the EIB’s venture debt instrument, will help Ryvu finance its development pipeline of new cancer treatments from discovery through to clinical trials. Ryvu’s […]

News round-up by DDW’s Reece Armstrong for 8-12 August  New insights into melanoma, a company transition into life sciences and a Lyme disease vaccine are some of the stories in this week’s news round-up. Pfizer launches Phase III trial for Lyme disease vaccine    Pfizer has launched a Phase III clinical trial of a vaccine to […]

Life sciences company PerkinElmer will divest its Applied, Food and Enterprise Services to the private equity firm New Mountain Capital in a potential deal worth $2.45 billion. PerkinElmer states that the deal comes at a pivotal moment for the company as it transitions to solely focusing on its Life Sciences and Diagnostics businesses. PerkinElmer says […]

Life sciences property provider Bruntwood SciTech has invested £20 million into redeveloped laboratories at the UK’s North West research campus, Alderley Park.   The £20 million investment has gone towards the redevelopment of existing lab spaces to create high-specification biology and chemistry containment level two (CL2) laboratory suites. The labs have been designed to include spaces […]

Techbio company Closed Loop Medicines has appointed two new members in support of its planned international growth.   Closed Loop Medicines appointed David Van Sickle as Non-Executive Director and Simon Ramsden as Chief Financial Officer.  Closed Loop Medicine says that the hires will help in the next stage of its growth as the company expands its […]

A UK centre for synthetic biology has received £5.5 million in funding so it can support start-ups and SMEs in the sector.  The UK’s National Centre for the Industrial Translation of Synthetic Biology, SynbiCITE, will use the funding to support businesses within the sector and to help strengthen the emerging UK bioeconomy. The centre was […]

Precision medicine start-up Vesynta has become the first medtech company to move into a laboratory at south London’s latest incubator space.   The company, which was spun out from the Adaptive and Responsive Nanomaterials group at University College London, has moved into the Innovation Gateway at The London Cancer Hub in Sutton. The start-up is developing a […]